Nestlé Health Science

Nestlé Health Science

Signal active

Investment Firm

Overview

Nestlé Health Science began operations on January 1, 2011. As a wholly-owned subsidiary of Nestlé, with global headquarters in Vevey, Switzerland, Nestlé Health Science has a distinct role to play in the Nestlé’s transformation into the world’s recognised leader in Nutrition, Health and Wellness. At Nestlé Health Science, their specific quest is to become the global leader in science-based personalised nutritional solutions.

Nestlé Health Science has been established to pioneer science-based nutritional solutions in order to deliver improved personalised healthcare for medical conditions. In the longer term, the company aims to use nutritional solutions to change the healthcare paradigm and deliver affordable and effective health benefits which are also safe and sustainable.

The company intends to use Nestlé's existing HealthCare Nutrition business to build a leading health science nutrition organisation within two years. It aims to develop a product portfolio and pipeline within five years and establish market leadership, meeting its vision, within a decade from start-up. The company has access to external scientific and technological know-how through Nestlés innovation network as well as a number of venture capital funds in which the group has interests.

Highlights

Founded

2011

Industry

Insurance

Employees

10001+

Investment

15

Lead Investment

7

Exits

4

Stages

Late Stage Venture, Private Equity

Investor Type

N/A

Location

Vevey, Vaud, Switzerland, Europe

Contact Information

Social

Profile Resume

Nestlé Health Science, established in 2011 and headquartered in Switzerland, Europe., specializes in Late Stage Venture, Private Equity investments across Biotechnology, Health Care, Biopharma, Therapeutics, Life Science, Software, E-Commerce, Marketplace, Retail, Sports. The organization boasts a portfolio of 15 investments, with an average round size of $69.8M and 4 successful exits. Their recent investments include Seres Therapeutics, ENTEROME, Seventure Partners, Omnes Capital, Lundbeckfonden Ventures. The highest investment round they participated in was $32.5B. Among their most notable exits are Seres Therapeutics and ENTEROME. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Paul Giannasca

Paul Giannasca

Global R&D Lead - Gut Health & Microbiome

imagePlace Peter Letmathe

Peter Letmathe

Chairman

imagePlace Hermann Wirz

Hermann Wirz

Director

imagePlace Emmanuel Baetge

Emmanuel Baetge

Director

imagePlace Gunnart Weikert

Gunnart Weikert

Director

imagePlace Nicholas Bredow

Nicholas Bredow

Search Engine Marketing Manager

Investment portfolio

Nestlé Health Science has made 15 investments. Their most recent investment was on Jan 17, 2024, when Timeline raised $64.8M.

investments

15

Diversity investments

0

Lead investments

7

Number of exits

4

Investments

15

Annouced DateOrganization NameIndustryMoney Raised
Jun 25, 2020
ENTEROME ENTEROME
Biotechnology51.9M
Jul 13, 2021
ProciseDx ProciseDx
Health Care13.0M
Dec 23, 2022--null
Jan 17, 2024
Timeline Timeline
Biotechnology64.8M

Exits

4

Funding Timeline

Funding rounds

15

Investors

0

Funds

0

Funding Rounds

15

Nestlé Health Science has raised 15 rounds. Their latest funding was raised on Jan 17, 2024 from a Series D - Timeline round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Jun 25, 2020
Series E - ENTEROME Series E - ENTEROME
-51.9M-
Jul 13, 2021
Convertible Note - ProciseDx Convertible Note - ProciseDx
-13.0M-
Dec 23, 2022
Private Equity Round - Ruipeng Pet Healthcare Private Equity Round - Ruipeng Pet Healthcare
-0-
Jan 17, 2024
Series D - Timeline Series D - Timeline
-64.8M-

Investors

0

There is no funding round available on this profile

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries